26 août 2022, Pharmaceutical Technology
This means these machines are often controlled from the outside, which makes research challenging, Zheng says. As a result, scaling up for clinical studies is difficult, says director of the nanorobotics laboratory at Polytechnique Montréal, Sylvain Martel, PhD.






